IP Library › Granted Patent US 8,870,810
Granted Patent B2
US 8,870,810 · App. 13/614,032 · Granted Oct 28, 2014

Method and apparatus for enhancement of transdermal transport

Inventors: Samir S. Mitragotri (Santa Barbara, CA); Joseph Kost (Omer, IL); Scott C. Kellogg (Boston, MA); Nicholas F Warner (Belmont, MA); Tuan A Elstrom (Lake Bluff, IL)
Assignee: Echo Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,870,810
App. No.
13/614,032
Granted
Oct 28, 2014
Kind
B2
Abstract

According to the present invention, a method for enhancing transdermal transport is disclosed. The method includes the steps of increasing a permeability an area of a membrane with a permeabilizing device. The membrane may be, inter alia, biologic skin or synthetic skin. The permeabilizing device may be an ultrasound-producing device. A substance is transported into and through the area the membrane. The substance may be a drug, a vaccine, or a component of interstitial fluid.

Claims (71)

1. A method for enhancing transdermal transport, comprising

(a) increasing the permeability of an area of skin with a skin permeabilizing device, wherein the device comprises a permeability monitoring circuit for monitoring at least one electrical parameter of the area of skin indicative of skin permeability, and wherein the device permeabilizes the skin using mechanical force;

(b) monitoring the at least one electrical parameter of the area of skin using the permeability monitoring circuit;

(c) controlling the mechanical force applied to the area of skin by the device based on the at least on electrical parameter; and

(d) transporting a substance into and through the area of skin via passive diffusion.

2. The method of claim 1 , further comprising

applying electricity to the area of skin.

3. The method of claim 1 , further comprising:

providing a first electrode in electrical contact with the area of skin;

providing a second electrode in electrical contact with the area of skin; and

measuring the at least one electrical parameter using the electrodes.

4. The method of claim 1 , wherein the step of transporting a substance across the area of skin comprises:

extracting a body fluid from or through said area of skin;

collecting said body fluid; and

sensing the presence of said at least one analyte in said body fluid.

5. The method of claim 1 , wherein the substance is a drug.

6. The method of claim 1 , wherein the substance includes at least one component of interstitial fluid.

7. A method for enhancing a permeability of an area of skin for drug delivery or analyte extraction comprising:

increasing the permeability of the area of skin with a skin permeabilizing device, wherein the skin permeabilizing device comprises a permeability monitoring circuit for monitoring at least one electrical parameter of the area of skin indicative of skin permeability and wherein the skin permeabilizing device permeabilizes the skin using mechanical force;

applying electricity to the area of skin;

measuring the at least one electrical parameter of the area of skin using the permeability monitoring circuit of the skin permeabilizing device; and

controlling the mechanical force applied to the area of skin by the skin permeabilizing device based on the at least one electrical parameter.

8. The method of claim 7 , further comprising:

applying electricity to the area of skin before increasing the permeability of the area of skin with a skin permeabilizing device; and

measuring a baseline for the at least one electrical parameter.

9. The method of claim 7 , further comprising:

coupling a first electrode with the area of skin;

coupling a second electrode with the skin; and

measuring the at least one electrical parameter using the first electrode and the second electrode.

10. The method of claim 9 , wherein the first electrode is coupled with a portion of stratum corneum of the area of skin.

11. The method of claim 10 , wherein the second electrode is coupled with a portion of epidermis over which the stratum corneum has been removed.

12. The method of claim 10 , wherein the second electrode is coupled with a portion of stratum corneum of the skin.

13. The method of claim 9 , wherein at least one of the first and second electrode is coupled through a conductive medium.

14. The method of claim 7 , further comprising:

comparing the at least one electrical parameter with the baseline, and

wherein the step of controlling the skin permeabilizing device comprises discontinuing the application of the skin permeabilizing device based on the comparison.

15. The method of claim 7 , wherein said application of said skin permeabilizing device is continuous.

16. The method of claim 7 , wherein said application of said skin permeabilizing device is discontinuous.

17. The method of claim 16 , further comprising the steps of

performing analog to digital conversion on said information on a time-variation of skin conductance; and

filtering said digital data.

18. The method of claim 7 , wherein the measuring step comprises measuring an initial conductivity and a second conductivity to establish information on a time-variation of skin conductance, and processing said information from the measuring step by fitting said information into the following equation:

C

=

Ci

+

(

C

f

-

C

i

)

1

+

ⅇ

S

⁡

(

t

-

t

*

)

where:

C is current;

C i is current at t=0;

C f is the final current;

S is a sensitivity constant;

t* is the exposure time required to achieve an inflection point; and

t is the time of exposure.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2012
From: MITRAGOTRI, SAMIR S.; KOST, JOSEPH; KELLOGG, SCOTT C.; WARNER, NICHOLAS F.; ELSTROM, TUAN A.
To: SONTRA MEDICAL, INC.
Reel/Frame 028985/0599 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2012
From: SONTRA MEDICAL, INC.
To: ECHO THERAPEUTICS, INC.
Reel/Frame 028985/0743 →
Continuity (8)
Continuation 10792862 · Mar 5, 2004
Division 09868442
Provisional Application 60142975 · Jul 12, 1999
Provisional Application 60142951 · Jul 12, 1999
Provisional Application 60142950 · Jul 12, 1999
Provisional Application 60142941 · Jul 12, 1999
Provisional Application 60112953 · Dec 18, 1998
Related Publication 20130035566A1 · Feb 7, 2013